chr19-16893305-C-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_015692.5(CPAMD8):c.5461G>A(p.Gly1821Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000879 in 1,549,726 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_015692.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CPAMD8 | NM_015692.5 | c.5461G>A | p.Gly1821Arg | missense_variant | 42/42 | ENST00000443236.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CPAMD8 | ENST00000443236.7 | c.5461G>A | p.Gly1821Arg | missense_variant | 42/42 | 1 | NM_015692.5 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000657 AC: 100AN: 152210Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000657 AC: 106AN: 161256Hom.: 1 AF XY: 0.000521 AC XY: 45AN XY: 86348
GnomAD4 exome AF: 0.000903 AC: 1262AN: 1397398Hom.: 4 Cov.: 31 AF XY: 0.000871 AC XY: 600AN XY: 688660
GnomAD4 genome AF: 0.000656 AC: 100AN: 152328Hom.: 0 Cov.: 33 AF XY: 0.000591 AC XY: 44AN XY: 74488
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.5602G>A (p.G1868R) alteration is located in exon 42 (coding exon 42) of the CPAMD8 gene. This alteration results from a G to A substitution at nucleotide position 5602, causing the glycine (G) at amino acid position 1868 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
See cases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University Hospital Muenster | Sep 09, 2022 | ACMG categories: PM2 - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 12, 2022 | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 1868 of the CPAMD8 protein (p.Gly1868Arg). This variant is present in population databases (rs201034139, gnomAD 0.2%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with CPAMD8-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at